The indices started the week in strong fashion. Although they were very choppy during the day, they did hold support for most of the session, and then came on again in the last hour, closing at the highs for the day going away, which are also the highs for this entire rally.

Net on the day the Dow was up 104.20 at 8848.15, the S&P 500 up 10.75 at 951.13, and the Nasdaq 100 up 16.74 at 1544.

Advance-declines were better than 3 to 1 positive on New York and about 2 ½ to 1 positive on Nasdaq. Up/down volume was about 3 ½ to 1 positive on New York on total volume of just 1.1 billion. Nasdaq traded just over 1.9 billion and had a nearly 5 to 1 volume ratio.

By far, the stock of the day today was Human Genome Sciences (HGSI), which soared 9.19 on positive drug news to close at 12.51, up 277% on 122 million shares.

That was our Chart of the Day (see link at right).

Goldman Sachs (GS) was up 3.19 to 160.03, and Apple (AAPL) up 1.16 to 152.91, although that reached over 155 earlier in the day.

Junior Biotech Orexigen (OREX) gained 1.51 to 7.20 on 7.3 million.

The iShares MSCI Brazil Index ETF (EWZ) advanced 1.66 to 55.72, and the iShares FTSE/Xinhua China 25 Index (FXI) was up 1.58 to 40.92.

Oil Services HLDRs (OIH) jumped 1.46 to 102.44, and the U.S. Oil Fund ETF (USO) gained 59 cents, as crude oil firmed today.

Other gainers of note, former portfolio position Cornerstone Therapeutics (CRTX) rose 59 cents to 9.01. Fuel System Solutions (FSYS) advanced 65 cents to 22.76, and low-priced Infosonics (IFON), a portfolio position, jumped 28 cents to 1.96, about 17 percent today.

Targacept (TRGT), another junior biotech, did well, up 51 cents to 8.37.

On the downside, the UltraShort Real Estate ProShares (SRS) lost 1.33 to 18.07, and the Direxion Financial Bear 3x Shares (FAZ) lost 1.29 to 41.01. Direxion Large Cap Bear 3X Shares (BGZ) lost 1 to 31.24, and the Direxion Small Cap 3x Bear (TZA) lost 81 cents to 19.68.

Stepping back and reviewing the hourly chart patterns, we gapped up in the morning, backed off and tested support and held, and then backed and filled for several hours in a coiling-type fashion, before a late afternoon breakout spurred the indices to new session and rally highs.

So another strong start to the week, but the NDX is now up 9 days in a row and the oscillators at this point are getting quite extended (NYSE McClellan oscillator now +202, NDX oscillator +102, SPX oscillator +96). The rally rolled on today and until it actually reverses upward momentum can continue.

But, I'm expecting a possible turnaround Tuesday tomorrow.

Good trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2009 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.